Chronic rhinosinusitis
Conditions
Interventions
experimental group 1:Unilateral posterior nasal neurotomy based on routine operation
experimental group 2:Bilateral posterior nasal neurotomy based on routine operation
Sponsors
The Second Hospital of Tianjin Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 to 60 years old; 2. According to the guidelines for the diagnosis and treatment of allergic rhinitis formulated in Tianjin in 2015, all patients were diagnosed with moderate to severe persistent AR, which had a serious impact on the quality of life. There were more than 2 common symptoms of AR, lasting or involving more than 1 hour every day. The nasal mucus was pale, edema or water like secretion. The allergen test was positive; 3. Patients with poor efficacy of drug therapy and / or failure of allergen specific immunotherapy require surgery and volunteer to participate in the trial.
Exclusion criteria
Exclusion criteria: 1. Patients who have not received standardized drug treatment or immunotherapy in the past; 2. Patients with asthma who are not controlled or complicated with mental diseases and immune deficiency; 3. Patients with coronary heart disease, hypertension, heart failure and other diseases can not tolerate surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective and objective score; | — |
Countries
China
Contacts
Public ContactShuang Yu
The Second Hospital of Tianjin Medical University
Outcome results
None listed